ENHO and obesity due to melanocortin 4 receptor deficiency: Adropin was demonstrated to play an essential role in activating downstream insulin signaling, maintaining glucose homeostasis and lipid metabolism, and guarding against obesity-related hyperinsulinemia and hepatic steatosis [9,10,11,12].